Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink (OLK) ® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
Drug discovery increasingly requires sophisticated analysis of proteins, and Thermo Fisher Scientific is building up its capabilities to support such research with the $3.1 billion acquisition of ...
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced the introduction of Olink ® Explore HT, a transformational solution for high-throughput proteomics ...
UPPSALA, Sweden,, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it has entered into an agreement with Discovery Life Sciences™ (Discovery) to ...
UPPSALA, Sweden, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now starting the delivery of Olink® Signature Q100, facilitating hands-on access for ...
Thermo Fisher Scientific has agreed to acquire Olink Holding for approximately $3.1 billion, the companies said today, in a deal intended to expand the buyer’s presence in proteomics. Headquartered in ...
WALTHAM, Mass. & UPPSALA, Sweden--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink ...
UPPSALA, Sweden and SHANGHAI, July 8, 2020 /PRNewswire/ -- WuXi NextCODE Genomics Co., Ltd. ("WuXi NextCODE") and Olink Proteomics AB today announced a strategic cooperation in China which gives WuXi ...
Olink Genomics offers Selector Technology as a service and through an early access program for customized kits. Karolinska Institutet researchers are to use Olink Genomics’ Selector Technology™ for ...
Olink Reveal is more than a proteomics kit—it’s a gateway for anyone starting with proteomics. Whether profiling the reactome or interrogating inflammation biomarkers, validating clinical targets, or ...
Large-scale study aims to create comprehensive map of the human proteome to monitor changes reflecting human health and disease The Geisinger Health Study, characterized by deep phenotyping data, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results